TMUS vs TTRX · P/E 19, rev $22.79B vs $187.1M cap
T-Mobile US Inc (TMUS) versus Turn Therapeutics Inc. Common Stock (TTRX) — a side-by-side from cached financials, not a winner call.
T-Mobile US Inc (TMUS) is a telecom services company listed on NASDAQ. It is led by Mike Sievert.
Turn Therapeutics Inc. Common Stock (TTRX) is a biotechnology company listed on NASDAQ.
Latest reported TMUS revenue for 2026-06-30 was $22.79B. Net income was $3.24B. Revenue was down 1.4% from 2026-03-31 to 2026-06-30. TMUS currently screens at market cap $196.21B and trailing P/E 19.3.
TTRX does not have a complete income-statement cache yet.
TMUS currently screens at market cap $196.21B and trailing P/E 19.3. TTRX currently screens at market cap $187.1M.
Not investment advice. Open the TMUS and TTRX stock pages for the full models.
Not investment advice.